US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.480
  • +0.140+4.19%
Close Oct 11 16:00 ET
  • 3.480
  • 0.0000.00%
Post 20:02 ET
293.79MMarket Cap-1657P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atea Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Feb 28, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Aug 7, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Feb 28, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Atea Pharmaceuticals Earnings Reports

  • Atea Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:52 ET

  • Atea Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 14 16:47 ET

  • Atea Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 28 22:56 ET

  • Atea Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 16:43 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data